ClinChoice
Sowmya Shree HK has extensive experience in regulatory affairs and quality assurance, currently serving as Lead Regulatory Affairs at ClinChoice since May 2022, focusing on global labeling, artwork, drug submissions, and DINA applications. Prior to this role, Sowmya worked at The Himalaya Drug Company from June 2016 to May 2022 as an Executive in Quality Assurance. Earlier experience includes a position as a QC Analyst in the Packaging Department at Remidex Pharma Pvt. Ltd. from May 2010 to May 2016, where responsibilities included sampling, analysis, documentation review and approval, validations, and gap analysis. Educational qualifications include a Master's degree in General Chemistry from Kuvempu University and a B.Sc. in Physics, Chemistry, and Mathematics from Hoysaleshwara First Grade College in Arsikere.
This person is not in any teams
This person is not in any offices
ClinChoice
2 followers
ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. With a 25 year history of success, ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance. ClinChoice has established major delivery centers across US, China, Europe, Canada, India, Japan and the Philippines. It has over 4,000 employees globally, with a strong and talented team, and a growing clinical operations presence in seven countries across Asia, North America and Europe.